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Aim To test the hypothesis that tSSEP findings reflect clin-
ical and MRI MS lesions, the aim of this study was to in-
vestigate tSSEP changes in patients with clinically isolated 
syndrome (CIS) in relation to clinical and brainstem MRI 
findings. The second aim was to investigate whether the 
interpretation of the tSSEP results in the form of the tSSEP 
score enables better evaluation of the afferent trigeminal 
pathway involvement than analyzing each tSSEP param-
eter separately.
Methods 115 consecutive CIS patients were enrolled from 
August 1, 2014 until March 1, 2016. Facial sensory symp-
toms and brainstem MRI (1.5 T) lesions were analyzed. 
tSSEP testing was performed for each patient from the raw 
tSSEP data. The tSSEP score was calculated separately for 
the left and right side (according to the cut-off values for 
absent response and prolonged latency of the main com-
ponent, P1 (0 = normal response, 1 = prolonged latency, 
3 = absent response) and the two values were summed.
Results There was no difference in the absolute values 
of the tSSEP variables regarding the presence of clinical 
symptoms. No association was found between tSSEP ab-
normalities and clinical symptoms (P = 0.544). Brainstem le-
sions (midbrain and pons) were associated with the absent 
tSSEP responses (P = 0.002 and P = 0.005, respectively). tSSEP 
score was significantly higher in patients with brainstem le-
sions (P = 0.01), especially midbrain (P = 0.004) and pontine 
(P = 0.008) lesions. Binary logistic regression showed that 
tSSEP score had a significant effect on the likelihood that 
patients have midbrain MR lesions, χ2(1) = 6.804, P = 0.009; 
and the model correctly classified 87% of cases.
Conclusions The consistent finding of this study was the 
association between tSSEP and midbrain lesions on MRI, 
indicating that tSSEP evaluates proprioception of the face. 
This study establishes the value of tSSEP in assessing brain-
stem function in early multiple sclerosis.
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Clinically isolated syndrome (CIS) is an acute or subacute 
episode of neurologic deficit and is a presenting syndrome 
in 85% of patients who will ultimately develop multiple 
sclerosis (MS). Most of CIS patients present with optic neu-
ritis, transverse myelitis, or brainstem/cerebellar symptoms, 
although a substantial number have multifocal symptoms 
(1). The affection of the brainstem in MS bears significant 
clinical importance. Patients with demyelinating lesions in 
the brainstem have a greater chance of having disability at 
follow-up than patients with no infratentorial lesions (2). 
Furthermore, they tend to have worse long term progno-
sis, and identification of these patients can influence im-
portant management decisions (3). Standard magnetic 
resonance imaging (MRI) of 1.5 Tesla field strength lacks 
sensitivity in detection of demyelinating lesions in the 
posterior fossa (4). Although MRIs of greater field strength, 
such as 3 or 7 Tesla, improve this shortcoming, the use of 
such machines is not yet widespread, and 7 Tesla MRI is 
mainly confined to research centers.
A common finding in MS patients are sensory symptoms 
(numbness, dysesthesia, or paresthesia) in trigeminal nerve 
regions (5). The trigeminal nerve is the most commonly in-
volved isolated cranial nerve in MS (6). Interestingly, senso-
ry symptoms associated with the trigeminal nerve damage 
in MS were found to be the only brainstem-specific symp-
toms negatively associated with the conversion to MS (7). 
Another problem with the trigeminal nerve involvement 
in MS is that even though high-resolution MRI at 3T yields 
a high prevalence of detectable trigeminal abnormalities, 
they did not correspond to trigeminal symptoms (8).
Several studies have been undertaken to improve the de-
tection of nervous system impairment in MS using evoked 
potentials (9,10). Initial studies using brainstem trigeminal 
evoked potentials proved them to be more sensitive than 
MRI in revealing brainstem lesions (11). In our earlier work, 
we have investigated the potential of tongue somatosenso-
ry evoked potentials (tSSEP) as an important part of neuro-
physiological brainstem evaluation in MS patients (12,13).
In order to test the hypothesis that tSSEP findings reflect 
clinical and MRI MS lesions, the aim of this study was to 
investigate tSSEP changes in patients with clinically iso-
lated syndrome (CIS) in relation to clinical and brainstem 
MRI findings. Furthermore, we wanted to investigate 
whether the interpretation of the tSSEP results in the form 
of the tSSEP score enables better evaluation of the affer-
ent trigeminal pathway involvement than analyzing each 
tSSEP parameter separately.
MATerIALS And MeTHodS
This study included consecutive patients diagnosed with 
CIS from August 1, 2014 until March 1, 2016 at the Depart-
ment of Neurology, University Hospital Center Zagreb. CIS 
diagnosis was made in patients with acute or subacute de-
velopment of neurological symptoms and/or signs lasting 
longer than 48 hours in the absence of fever or infection, 
and with at least one demyelinating lesion larger than 3 
mm on the brain and/or spinal cord MRI. The exception 
were patients with optic neuritis who were included if 
the classical clinical triad was present (rapidly develop-
ing impairment of vision, dyschromatopsia, and retro-or-
bital pain), accompanied by prolonged latencies of visu-
al evoked potentials, irrespective of the presence of brain 
and/or spinal cord MRI lesion.
All patients were recruited after the MRI was performed 
and CIS diagnosis made. tSSEP testing was performed 
on the day of recruitment (median 35 days after the MRI, 
range from 0 to 206). The study was approved by the Ethics 
Committees of the University Hospital Center Zagreb and 
University of Zagreb, School of Medicine. All participants 
signed the informed consent.
Clinical symptoms
All symptoms and signs pertaining to trigeminal involve-
ment were recorded. These consisted of face and/or 
tongue pain, paresthesia, or hypoesthesia. The side of the 
face or tongue on which the symptoms were present was 
recorded as well.
Tongue somatosensory evoked potentials (tSSeP)
tSSEP was performed according to previously published 
methods (12). Stimulation was delivered using modified 
EEG electrodes, located on the lateral side of the first two 
thirds of the tongue, and each side of the tongue was 
stimulated twice with 300 trials. Twister constant current 
stimulator was also used (Dr Langer Medical GmbH, Wald-
kirch, Germany). The frequency of the stimulation was 3 Hz 
and the duration of each stimulus was 0.2 ms. The cortical 
response was recorded from two surface disk electrodes 
situated on the contralateral side of the scalp, according 
to the International 10/20 system, at the middle position 
between C3 and T3 for the stimulation of the right side 
of the tongue – C5 electrode; and at the middle posi-
tion between C4 and T4 for the stimulation of the left 
side of the tongue – C6 electrode and referred to the 
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frontal electrode (Fz). The responses were recorded using a 
Brain Products Vision Recorder (Brain Products GmbH, Mu-
nich, Germany) and the recorded data were analyzed using 
a Brain Products Vision Analyzer. Latencies and amplitudes 
of the main components (N1, P1, N2) were analyzed in the 
form of absolute values and in the form of binary variables 
representing prolonged latency of P1 component, absent 
response of tSSEP pathology (absent response), and any 
tSSEP pathology (prolonged latency or absent response). 
Latency was considered prolonged if there was an increase 
of >2.5 standard deviations to the mean value for labora-
tory’s normative data.
In order to incorporate all tSSEP abnormalities in one vari-
able we developed tSSEP score based on the information 
about prolonged latencies and absent response. Because 
we found no statistically significant differences in the am-
plitudes of the main components between healthy con-
trols and MS patients in our previous work and because 
N1 and N2 waves due to large variability are often unde-
tectable and cause irregular morphology, we excluded 
amplitudes from the tSSEP score analysis (12,13). The tSSEP 
score was calculated from the raw tSSEP data according to 
cut-off values for absent response and prolonged latency 
of the main component, P1 (0 = normal response, 1 = pro-
longed latency, 3 = absent response). It was calculated 
separately for the left (left tSSEP) and the right side (right 
tSSEP) and the two values were summed.
MrI
All MRIs were performed on a 1.5T MRI scanner. Only brain-
stem multi-planar dual fast spin-echo PD and T2-WI se-
quences were analyzed for the presence of demyelinat-
ing lesions in the brainstem as a whole, and the midbrain, 
pons, and medulla oblongata separately. Furthermore, this 
involvement was then subdivided into right or left. If the 
lesion was located in the center of the brainstem, this was 
considered as bilateral, left, and right involvement. All MRIs 
were reviewed by two independent investigators (MH and 
LC), who were blinded to the patient’s symptoms at the 
time of analysis, and only lesions identified by both investi-
gators were considered as present.
outcomes
The primary outcome of this study was to determine the 
prevalence of tSSEP abnormalities in patients with CIS, 
and to correlate these abnormalities with clinical symp-
toms and brainstem MRI.
Secondary outcomes were to determine whether the in-
terpretation of the tSSEP results in the form of the tSSEP 
score enables better evaluation of the afferent trigeminal 
pathway involvement than analyzing each tSSEP param-
eter separately.
Statistical analysis
Statistical analysis was performed using the IBM SPSS soft-
ware, version 20 (Armonk, NY, USA). Values are presented 
as a mean with standard deviation or median with rang-
es. The Kolmogorov-Smirnov test was applied to test the 
normality of distribution. Differences in the distribution 
of qualitative variables were determined using the χ2 test, 
while the differences in quantitative variables were deter-
mined using the t test and Mann-Whitney test. Logistic re-
gression was used in order to determine which variables 
were significant predictors for a specific model. P values 
lower than 0.05 or corrected with Bonferroni correction 
were considered as significant.
reSuLTS
Patients
We enrolled 115 CIS patients, mean age 32.5 ± 8.6, 82 
(71.3%) women, with a median Expanded Disability Status 
Scale (EDSS) of 1.0 (0-3.5); 36 (31.3%) patients presented 
with optic neuritis, 36 (31.3%) with incomplete transverse 
myelitis, 27 (23.5%) with brainstem/cerebellar symptoms, 
12 (10.4%) with hemispheral involvement, and 4 (3.5%) 
with multifocal involvement. Patients’ symptoms and 
brainstem MRI lesion distribution are shown in Table 1.
Primary outcomes
Descriptive tSSEP values and proportion of patients with 
tSSEP abnormalities (prolonged latencies and absent re-
sponses) are presented in Tables 2 and 3. There was no sig-
nificant difference in the absolute values of the tSSEP vari-
ables (latencies and amplitudes) between patients with 
and without clinical symptoms. Also, there was no signifi-
cant difference in tSSEP variables for the right side regard-
ing the presence of the right side MRI lesions. Patients who 
had MRI lesions in the left medulla oblongata had signifi-
cantly prolonged latency of P1 component (22.9 ± 2.1 vs 
21.2 ± 1.6, P = 0.006), while other variables did not show 
significant difference.
There was no significant association between brainstem 
MRI lesions and clinical symptoms (Table 4). Furthermore, 
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brainstem lesions (midbrain and pontine lesions specifi-
cally) were associated with the absent tSSEP responses 
(P = 0.002 and P = 0.005, respectively) (Table 4). There was 
no association between clinical symptoms and tSSEP ab-
normalities (P = 0.544) (prolonged latencies and absent re-
sponses; P = 1.00, and P = 1.00, respectively). In order to see 
whether these differences were left/right specific, we com-
pleted the analysis for each side separately (Table 5).
Secondary outcomes
tSSEP score was calculated for each patient, the medi-
an tSSEP score for the left side was 0 (range, 0-3), for the 
right side was 0 (range, 0-3), and overall tSSEP score was 
0 (range, 0-6). There was no difference in tSSEP score be-
tween patients with and without clinical symptoms, how-
ever tSSEP score was significantly higher in patients with 
brainstem lesions, especially midbrain (P = 0.004) and pon-
tine lesions (P = 0.008) (Table 6). In order to see whether 
these differences were left/right specific, we completed 
the analysis for each side separately, and found higher 
tSSEP score for the left side in patients with midbrain and 
pontine lesions (Table 7).
Finally, we performed binary logistic regression in or-
der to investigate the effect of tSSEP score on the likeli-
hood that patients have midbrain MRI lesions. The logistic 
model was significant, χ2 (1) = 6.804, P = 0.009. It explained 
10.7% (Nagelkerke R2) of the variance in presence of mid-
brain MR lesions and correctly classified 87% of cases. The 
tSSEP score was a significant predictor for midbrain lesions 
(P = 0.007, Exp(B) = 1.466).
dISCuSSIon
Two main findings of this study are: 1) tSSEP abnormalities 
are associated with midbrain lesions in CIS patients; and 2) 
the tSSEP score is a significant predictor for the presence of 
midbrain lesions in CIS patients.
TABLe 1. Patients’ symptoms and brainstem magnetic reso-
nance imaging (MrI) lesion distribution
Present, n (%) Absent, n (%)
Clinical symptoms
overall 13 (11.3) 102 (88.7)
left  6 (5.2) 109 (94.8)
right  8 (7.0) 107 (93.0)
Brainstem MrI
overall 48 (41.7)  67 (58.3)
left 33 (28.7)  82 (71.3)
right 33 (28.7)  82 (71.3)
Midbrain MrI
overall 15 (13.0) 100 (87.0)
left 11 (9.6) 104 (90.4)
right 10 (8.7) 105 (91.3)
Pontine MrI
overall 35 (30.4)  80 (69.6)
left 25 (21.7)  90 (78.3)
right 24 (20.9)  91 (79.1)
Medulla oblongata MrI
overall 17 (14.8)  98 (85.2)
left 11 (9.6) 104 (90.4)
right 16 (13.9)  99 (86.1)
TABLe 2. descriptive values for tongue somatosensory evoked 
potentials (tSSeP) latencies (lat) and amplitudes (amp)*




N1 lat (ms) (81) 15.15 12.80 19.20 1.38
N1 A (µV) (81) -0.65 -3.80 1.10 0.88
P1 lat (ms) (102) 21.48 15.40 26.20 1.75
P1 A (µV) (102) 1.39 -2.20 4.10 0.95
N2 lat (ms) (81) 28.32 24.20 32.20 1.92
N2 A (µV) (81) -0.31 -3.40 1.40 0.92
Left tSSeP
N1 lat (ms) (80) 15.16 12.40 20.00 1.47
N1 A (µV) (80) -0.36 -2.30 1.10 0.70
P1 lat (ms) (100) 21.31 17.40 26.60 1.67
P1 A (µV) (100) 1.44 -1.50 4.30 1.05
N2 lat (ms) (79) 27.90 23.40 34.00 2.04
N2 A (µV) (79) -0.24 -1.90 2.30 0.76
*13 patients had absent response for the right side stimulation, and 15 
patients had absent response for the left side. n1 and n2 waves have 
large variability, due to difficulties with their detection.
TABLe 3. The proportion of patients with tongue somatosen-
sory evoked potentials (tSSeP) abnormalities
Present n (%) Absent n (%)
Prolonged tSSeP latency
overall 14 (15.2)  78 (84.8)
left 11 (11.0)  89 (89.0)
right  7 (6.9)  95 (93.1)
Absent tSSeP response (conduction block)
overall 23 (20.0)  92(80.0)
left 15 (13.0) 100 (87.0)
right 13 (11.3) 102 (88.7)
Any pathology of the tSSeP response
overall 37 (32.2)  78 (67.8)
left 26 (22.6)  89 (77.4)
right 20 (17.4)  95 (82.6)
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In recent years there has been an increase in interest in 
neurophysiological assessment of MS patients despite the 
dominant role of MRI in the disease diagnosis and moni-
toring. This is mainly due to two reasons. First, as already 
mentioned, standard MRI sequences (T2, FLAIR, and T1 af-
ter application of gadolinium) lack the sensitivity for detec-
tion of demyelinating lesions in the posterior fossa. Sec-
ond, MRI is used solely for morphological assessment and 
does not provide information on functional integrity of the 
presented structures. Connor et al (14) demonstrated that 
multimodal evoked potentials were useful as an instru-
ment of measuring clinical disability in MS. Further studies 
provided evidence that evoked potentials may also play a 
role in predicting disability in MS patients (9,10). However, 
these studies assessed brainstem dysfunction using only 
brainstem auditory evoked potentials (BAEP), a method 
that evaluates just one of the numerous pathways in that 
area of the central nervous system. Additional mode of 
brainstem assessment is the vestibular evoked myogenic 
potentials (VEMP), which have shown to be of value in the 
evaluation of brainstem involvement in MS (15).
Previous studies have shown that MS patients have signifi-
cantly prolonged latencies on tSSEP compared to healthy 
controls (12,13,16). The present study showed that tSSEP 
abnormalities were associated with midbrain lesions. The 
trigeminal nerve has three principal sensory nuclei: the 
primary sensory nucleus (touch and position sensation), 
mesencephalic nucleus (proprioception), and the spinal 
nucleus and tract (pain and temperature sensation). With 
the intrapontine fascicular part of the trigeminal nerve 
they form the brainstem part of the trigeminal afferent 
pathway (5). MRI studies have shown that the intrapontine 
fascicular part of the trigeminal nerve is most frequent-
ly affected, while the lesions in the spinal nucleus and 
tract and the intrapontine fascicular part of the trigemi-
nal nerve correspond with trigeminal neuralgia (5). On the 
other hand, in none of the published studies pain, tem-
perature, and/or touch sensation correlated with the pres-
ence of brainstem lesions (17). Investigating propriocep-
tion of the face is very difficult (18), and no studies have 
been performed on MS patients. The consistent finding of 
the present study was the association between tSSEP and 
midbrain lesions on the MRI, indicating that tSSEP evalu-
ates proprioception of the face. This could explain no as-
sociation between patient-reported symptoms and tSSEP 
results. Initial studies of the trigeminal nerve SSEP have 
proven to be an objective, non-invasive measurement 
of facial proprioception (19,20), and our study confirms 
these observations with an excellent neurophysiological-
MRI association. Further studies investigating the clinical 
involvement of facial proprioception and tSSEP are war-
ranted. Because the aim of our study was to investigate 
the tSSEP changes in relation to brainstem MRI findings 
we wanted to investigate if there were any side specific 
associations between the tSSEP variable for the specific 
side and the MRI lesion on the same side. The reason why 
statistical significance was obtained only for the left side 
TABLe 4. Correlations between magnetic resonance imaging 
(MrI) parameters, clinical symptoms, and tongue somatosen-
sory evoked potentials (tSSeP) pathologies (Bonferroni cor-
rected P-value = 0.0125).
MrI lesions n* P* P value
Clinical symptoms
brainstem N 63 4 0.040
P 39 9
midbrain N 89 11 0.678
P 13 2
pons N 74 6 0.062
P 28 7
medulla oblongata N 88 10 0.405
P 14 3
Prolonged tSSeP latency
brainstem N 51 10 0.766
P 27 4
midbrain N 72 13 1.000
P 6 1
pons N 60 10 0.736
P 18 4
medulla oblongata N 69 12 1.000
P 9 2
Absent tSSeP response (conduction block)
brainstem N 61 6 0.001
P 31 17
midbrain N 85 15 0.002
P 7 8
pons N 70 10 0.005
P 22 13
medulla oblongata N 81 17 0.105
P 11 6
Any pathology of the tSSeP response
brainstem N 51 16 0.028
P 27 21
midbrain N 72 28 0.019
P 6 9
pons N 60 20 0.017
P 18 17
medulla oblongata N 69 29 0.169
P 9 8
*n – negative, P – positive.
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could be explained with higher numbers of tSSEP pathol-
ogies on the left side.
Another aspect of the study is the interpretation of the 
evoked potential results in the form of the score, be-
cause this method enables more comprehensive evalu-
ation of the observed changes. We developed the tSSEP 
score calculation on the basis of prior evoked potentials 
studies (21). The tSSEP score was significantly higher in 
patients with brainstem lesions on the MRI, specifically 
midbrain lesions for each side. Studies that have used 
BAEP as the method of choice for evaluating brainstem 
dysfunction did not find it to correlate well with clinical 
symptoms (9). Some studies have indicated that VEMPs 
could replace the BAEP, as it shows good correlations 
with the EDSS (14). Thus, the important finding of this 
study is that tSSEP represents a brainstem evoked poten-
tial test that shows good association with the presence 
TABLe 5. Correlations between magnetic resonance imaging (MrI) parameters, clinical symptoms, and tongue somatosensory 
evoked potentials (tSSeP) pathologies regarding left and right side distribution (Bonferroni corrected P value = 0.0125).
right Left
n* P* P value n P P value
Clinical symptoms
brainstem N 79 3 0.042 brainstem N 79 3 0.352
P 28 5 P 30 3
midbrain N 98 7 0.529 midbrain N 98 6 1.000
P 9 1 P 11 0
pons N 87 4 0.058 pons N 87 3 0.116
P 20 4 P 22 3
medulla oblongata N 93 6 0.308 medulla oblongata N 98 6 1.000
P 14 2 P 11 0
Prolonged tSSeP latency
brainstem N 69 5 1.000 brainstem N 69 6 0.136
P 26 2 P 20 5
midbrain N 89 6 0.402 midbrain N 85 9 0.129
P 6 1 P 4 2
pons N 75 5 0.642 pons N 76 6 0.025
P 20 2 P 13 5
medulla oblongata N 83 6 1.000 medulla oblongata N 84 8 0.041
P 12 1 P 5 3
Absent tSSeP response (conduction block)
brainstem N 74 8 0.516 brainstem N 75 7 0.033
P 28 5 P 25 8
midbrain N 95 10 0.085 midbrain N 94 10 0.006
P 7 3 P 6 5
pons N 80 11 1.000 pons N 82 8 0.020
P 22 2 P 18 7
medulla oblongata N 89 10 0.388 medulla oblongata N 92 12 0.155
P 13 3 P 8 3
Any pathology of the tSSeP response
brainstem N 69 13 0.588 brainstem N 69 13 0.008
P 26 7 P 20 13
midbrain N 89 16 0.070 midbrain N 85 9 0.003
P 6 4 P 4 2
pons N 75 16 1.000 pons N 76 14 0.001
P 20 4 P 13 12
medulla oblongata N 83 16 0.475 medulla oblongata N 84 20 0.016
P 12 4 P 5 6
*n – negative, P – positive.
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of demyelinating lesions on MRI, supporting its use in MS 
evaluation. Future studies combining different brainstem 
evoked potentials in the form of scores may prove to be 
useful in monitoring and/or predicting disease activity 
in MS patients.
This study has several limitations. The first is that all MRI were 
performed on 1.5T MRI. However, although 3T MRI provides 
higher sensitivity in the detection of MS lesions, especially 
in the infratentorial region, it is not widely available. Further-
more, although healthy controls were not included in this 
study, we used the reference values of our laboratory.
In conclusion, this study establishes the value of tSSEP in 
evaluating brainstem function in CIS. As there have been 
several studies evaluating evoked potentials as a prog-
nostic method, future studies should include tSSEP as 
a valuable addition.
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